Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
631 Pharmacokinetics and pharmacodynamics study of TU2218, TGFβRI and VEGFR2 dual inhibitor in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
